Brief: Mersana Therapeutics Q4 EPS USD -0.16
28/02/2024 12:00
Feb 28 (Reuters) - Mersana Therapeutics Q4 net income USD -19.544 million. * Q4 collaboration revenue USD 10.701 million
MRSN — Mersana Therapeutics News Story
0.000.00%
Last trade - 00:00- $145.16m
- $88.77m
- $40.50m